Improved prediction of alzheimer's disease with longitudinal white matter/gray matter contrast changes

Human Brain Mapping

Volumn 34, Issue 11, 2013, Pages 2775-2785

  Grydeland, Håkon ^a   Westlye, Lars T ^a   Walhovd, Kristine B ^a   Fjell, Anders M ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Cerebral cortex; Cortical thickness; Disease prediction; Entorhinal; Hippocampus; MRI T1 weighted signal intensity; Tissue contrast

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ALZHEIMER DISEASE; AREA UNDER THE CURVE; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN DEGENERATION; BRAIN MAPPING; CALCULATION; CLINICAL DEMENTIA RATING; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ENTORHINAL CORTEX; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; IMAGE QUALITY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; TEMPORAL LOBE; WHITE MATTER; ATROPHY; BRAIN; EDUCATIONAL STATUS; IMAGE PROCESSING; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PSYCHOLOGY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SOCIOECONOMICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AREA UNDER CURVE; ATROPHY; BRAIN; CEREBRAL CORTEX; EDUCATIONAL STATUS; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SOCIOECONOMIC FACTORS;

EID: 84886297034     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22103     Document Type: Article

References (45)

1. Bakkour A, Morris JC, Dickerson BC (2009): The cortical signature of prodromal AD: Regional thinning predicts mild AD dementia. Neurology 72:1048-1055.
2. Barbier EL, Marrett S, Danek A, Vortmeyer A, van Gelderen P, Duyn J, Bandettini P, Grafman J, Koretsky AP (2002): Imaging cortical anatomy by high-resolution MR at 3.0T: Detection of the stripe of Gennari in visual area 17. Magn Reson Med 48:735-738.
3. Barnes J, Bartlett JW, van de Pol LA, Loy CT, Scahill RI, Frost C, Thompson P, Fox NC (2009): A meta-analysis of hippocampal atrophy rates in Alzheimer's disease. Neurobiol Aging 30:1711-1723.
4. Berg L (1988): Clinical dementia rating (CDR). Psychopharmacol Bull 24:637-639.
5. Braak H, Braak E (1991): Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259.
6. Braak H, Braak E (1996): Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol 92:197-201.
7. Clark VP, Courchesne E, Grafe M (1992): In vivo myeloarchitectonic analysis of human striate and extrastriate cortex using magnetic resonance imaging. Cereb Cortex 2:417-424.
8. Dale AM, Fischl B, Sereno MI (1999): Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9:179-194.
9. Davatzikos C, Resnick SM (2002): Degenerative age changes in white matter connectivity visualized in vivo using magnetic resonance imaging. Cereb Cortex 12:767-771.
10. de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Rusinek H, Li J, Tsui W, Saint Louis LA, Clark CM, Tarshish C, Li Y, Lair L, Javier E, Rich K, Lesbre P, Mosconi L, Reisberg B, Sadowski M, DeBernadis JF, Kerkman DJ, Hampel H, Wahlund LO, Davies P (2006): Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging 27:394-401.
11. DeLong ER, DeLong DM, Clarke-Pearson DL (1988): Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845.
12. Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006): An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968-980.
13. Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, Stern Y, Tabert MH, de Leon MJ (2007): Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease. Neurology 68:828-836.
14. Dickerson BC, Goncharova I, Sullivan MP, Forchetti C, Wilson RS, Bennett DA, Beckett LA, deToledo-Morrell L (2001): MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging 22:747-754.
15. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007): Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734-746.
16. Eickhoff S, Walters NB, Schleicher A, Kril J, Egan GF, Zilles K, Watson JD, Amunts K (2005): High-resolution MRI reflects myeloarchitecture and cytoarchitecture of human cerebral cortex. Hum Brain Mapp 24:206-215.
17. Fischl B, Dale AM (2000): Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 97:11050-11055.
18. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002): Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron 33:341-355.
19. Fischl B, Salat DH, van der Kouwe AJ, Makris N, Segonne F, Quinn BT, Dale AM (2004a): Sequence-independent segmentation of magnetic resonance images. Neuroimage 23( Suppl 1):S69-S84.
20. Fischl B, Sereno MI, Dale AM (1999): Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 9:195-207.
21. Fischl B, van der Kouwe A, Destrieux C, Halgren E, Segonne F, Salat DH, Busa E, Seidman LJ, Goldstein J, Kennedy D, Caviness V, Makris N, Rosen B, Dale AM (2004b): Automatically parcellating the human cerebral cortex. Cereb Cortex 14:11-22.
22. Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM (2010): CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease. J Neurosci 30:2088-2101.
23. Fotenos AF, Snyder AZ, Girton LE, Morris JC, Buckner RL (2005): Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD. Neurology 64:1032-1039.
24. Frisoni GB, Fox NC, Jack CRJr, Scheltens P, Thompson PM (2010): The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6:67-77.
25. Hagler DJJr, Saygin AP, Sereno MI (2006): Smoothing and cluster thresholding for cortical surface-based group analysis of fMRI data. Neuroimage 33:1093-1103.
26. Han X, Jovicich J, Salat D, van der Kouwe A, Quinn B, Czanner S, Busa E, Pacheco J, Albert M, Killiany R, Maguire P, Rosas D, Makris N, Dale A, Dickerson B, Fischl B (2006): Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer. Neuroimage 32:180-194.
27. Hayasaka S, Nichols TE (2003): Validating cluster size inference: Random field and permutation methods. Neuroimage 20:2343-2356.
28. Jack CRJr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC (2009): Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease. Brain 132( Pt 5):1355-1365.
29. Jack CRJr, Petersen RC, O'Brien PC, Tangalos EG (1992): MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 42:183-188.
30. Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CRJr, Weiner MW, Jagust WJ (2010): Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 75:230-238.
31. Marcus DS, Fotenos AF, Csernansky JG, Morris JC, Buckner RL (2010): Open access series of imaging studies: Longitudinal MRI data in nondemented and demented older adults. J Cogn Neurosci 22:2677-2684.
32. McDonald CR, McEvoy LK, Gharapetian L, Fennema-Notestine C, Hagler DJJr, Holland D, Koyama A, Brewer JB, Dale AM (2009): Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology 73:457-465.
33. Reuter M, Fischl B (2011): Avoiding asymmetry-induced bias in longitudinal image processing. NeuroImage 57:19-21.
34. Reuter M, Rosas HD, Fischl B (2010): Highly accurate inverse consistent registration: A robust approach. Neuroimage 53:1181-1196.
35. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M (2011): pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12:77.
36. Salat DH, Chen JJ, van der Kouwe AJ, Greve DN, Fischl B, Rosas HD (2011): Hippocampal degeneration is associated with temporal and limbic gray matter/white matter tissue contrast in Alzheimer's disease. Neuroimage 54:1795-1802.
37. Salat DH, Lee SY, van der Kouwe AJ, Greve DN, Fischl B, Rosas HD (2009): Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrast. Neuroimage 48:21-28.
38. Sigalovsky IS, Fischl B, Melcher JR (2006): Mapping an intrinsic MR property of gray matter in auditory cortex of living humans: A possible marker for primary cortex and hemispheric differences. Neuroimage 32:1524-1537.
39. Sled JG, Zijdenbos AP, Evans AC (1998): A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17:87-97.
40. Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CRJr (2009): MRI and CSF biomarkers in normal, MCI, and AD subjects: Diagnostic discrimination and cognitive correlations. Neurology 73:287-293.
41. Vickers AJ, Cronin AM, Begg CB (2011): One statistical test is sufficient for assessing new predictive markers. BMC Med Res Methodol 11:13.
42. Walhovd KB, Fjell AM, Brewer J, McEvoy LK, Fennema-Notestine C, Hagler DJJr, Jennings RG, Karow D, Dale AM (2010): Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. AJNR Am J Neuroradiol 31:347-354.
43. Walters NB, Egan GF, Kril JJ, Kean M, Waley P, Jenkinson M, Watson JD (2003): In vivo identification of human cortical areas using high-resolution MRI: An approach to cerebral structure-function correlation. Proc Natl Acad Sci USA 100:2981-2986.
44. Westlye LT, Walhovd KB, Dale AM, Bjornerud A, Due-Tonnessen P, Engvig A, Grydeland H, Tamnes CK, Ostby Y, Fjell AM (2010): Differentiating maturational and aging-related changes of the cerebral cortex by use of thickness and signal intensity. Neuroimage 52:172-185.
45. Westlye LT, Walhovd KB, Dale AM, Espeseth T, Reinvang I, Raz N, Agartz I, Greve DN, Fischl B, Fjell AM (2009): Increased sensitivity to effects of normal aging and Alzheimer's disease on cortical thickness by adjustment for local variability in gray/white contrast: A multi-sample MRI study. Neuroimage 47:1545-1557.